7 results match your criteria: "Asklepieio General Hospital[Affiliation]"
Crit Care
March 2024
4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Cytokine
February 2023
4(th) Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece; Hellenic Institute for the Study of Sepsis, Athens, Greece. Electronic address:
Objectives: Elevated concentrations of soluble urokinase plasminogen activator receptor (suPAR) predict progression to severe respiratory failure (SRF) or death among patients with COVID-19 pneumonia and guide early anakinra treatment. As suPAR testing may not be routinely available in every health-care setting, alternative biomarkers are needed. We investigated the performance of C-reactive protein (CRP), interferon gamma-induced protein-10 (IP-10) and TNF-related apoptosis-inducing ligand (TRAIL) for predicting SRF or death in COVID-19.
View Article and Find Full Text PDFLupus
December 2022
Department of Rheumatology, "Asklepieio" General Hospital, Athens, Greece.
Objective: The proportion of SLE patients with residual disease activity in routine settings is variable. We assessed disease activity state in patients during their most recent visit, and whether patients with residual activity were offered therapy intensification.
Methods: Cross-sectional study of consecutive lupus patients in three tertiary centers.
Eur J Heart Fail
April 2022
Heart Failure Unit, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Nat Med
October 2021
4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
Nat Med
October 2021
4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
Early increase of soluble urokinase plasminogen activator receptor (suPAR) serum levels is indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to respiratory failure. The SAVE-MORE double-blind, randomized controlled trial evaluated the efficacy and safety of anakinra, an IL-1α/β inhibitor, in 594 patients with COVID-19 at risk of progressing to respiratory failure as identified by plasma suPAR ≥6 ng ml, 85.9% (n = 510) of whom were receiving dexamethasone.
View Article and Find Full Text PDFWorld J Emerg Surg
November 2012
1st Surgical Department, Asklepieio General Hospital, Voula, Greece.
Non-occlusive colonic ischaemia is a recognized albeit rare entity related to low blood flow within the visceral circulation and in most reported cases the right colon was affected. This is the second case report in the literature of extensive colonic necrosis following cardiac arrest and cardiopulmonary resuscitation (CPR). A 83-year-old Caucasian woman was admitted to our hospital due to a low energy hip fracture.
View Article and Find Full Text PDF